BooksTestimonialsInterviewsLibraryArticlesShop Here 

Articles

News articles.

3 Reasons 2 Snack on Pumpkin Seeds 4 Those w/ Advanced Hepatitis

By Nicole Cutler, L.Ac.

Once October hits, pumpkins are placed front and center in a majority of American supermarkets, kitchen counters and front porches. The pumpkin's seeds frequently get scooped and tossed when making Jack-O-lanterns or in favor of the gourd's bright orange flesh for pie making. However, pumpkin seeds are virtual nutrient powerhouses that harbor several benefits to people with a chronic illness - especially those with advanced hepatitis.

Four bitter herbs heal the liver, gall bladder, and other ailments

(NaturalNews) Certain bitter herbs are considered liver herbs because they stimulate, cleanse, and protect the liver and gall bladder. While Western palates are not fond of bitter tasting foods, they do stimulate and support digestion. German research shows that bitter tonic herbs stimulate bile and hydrochloric acid production. They stimulate nervous system and immune system function, as well as combat fatigue and exhaustion.

Fructose consumption shown to damage liver by altering energy balance

(NaturalNews) Mortality from diseases of the liver has increased over the past half-century to secure a place as one of the top, leading causes of death each year in the United States. One hundred years ago, liver disease was virtually unheard of except for the occasional death from alcoholic cirrhosis. Today, non-alcoholic fatty liver disease (NAFLD) is a common diagnosis caused by an inability to effectively clear fat stores from the organ. Metabolic function quickly becomes compromised and liver failure can be a potentially fatal result.

The Most Epic Drug Failure. Ever.

By Dr. Mercola

Only a week after the U.S. Centers for Disease Control and Prevention (CDC) advised all U.S. baby boomers to get tested for hepatitis C because it’s suspected that millions may be infected with it, a drug company with a hepatitis C treatment in the pipeline has suddenly abandoned the drug’s trials.

Folic acid might be losing its sheen

Credited with lowering the rates of some birth defects, the vitamin also has been linked to a higher likelihood of some cancers.

BMS Halts Hep C Drug Work After Patient Dies

Bristol-Myers Squibb announced late Thursday that it's stopping development of an investigational drug for hepatitis C virus (HCV) infection after a patient died of heart failure and eight others were hospitalized.

The drug, an HCV nucleotide polymerase inhibitor called BMS-986094, was being tested in a phase II trial when the case of heart failure was identified. The trial was halted earlier this month.

Bristol-Myers Ends a Hepatitis C Project

Bristol-Myers Squibb said Thursday that it was discontinuing development of a hepatitis C drug that it had acquired in a $2.5 billion deal, after nine patients in a clinical trial had to be hospitalized and one of them died.

The company suspended testing of the drug on Aug. 1, after one patient in a midstage clinical trial experienced heart failure. At that time, however, there was still some question of whether the drug, known as BMS-986094, had caused the problem.

But Thursday evening, the company said that initial patient had died and that eight other patients also had to be hospitalized. Two of them remained hospitalized.

Syndicate content